Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Sarepta Therapeutics Inc (SRPT)  
$128.77 1.38 (1.08%) as of 4:30 Fri 4/26


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 84,190,000
Market Cap: 10.84(B)
Last Volume: 427,350 Avg Vol: 426,157
52 Week Range: $67.31 - $157.19
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 16.7
Insider 3/6 Months : 17.3
Guru Rank Number :  983
Guru Rank Value     : 0
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   Sarepta Therapeutics is a commercial-stage biopharmaceutical company focused on helping patients through the discovery and development of RNA-targeted therapeutics, gene therapy and other genetic therapeutic modalities for the treatment of rare diseases. Co. is developing therapeutic candidates for a range of diseases and disorders, including Duchenne muscular dystrophy, Limb-girdle muscular dystrophies and other neuromuscular and central nervous system related disorders. Co.'s commercial product, EXONDYS 51® (eteplirsen) Injection is indicated for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 75,225 143,757 247,027
Total Buy Value $0 $5,942,300 $13,295,068 $24,257,422
Total People Bought 0 2 3 3
Total Buy Transactions 0 2 5 7
Total Shares Sold 24,096 24,096 39,096 39,954
Total Sell Value $2,990,141 $2,990,141 $4,590,941 $4,685,252
Total People Sold 6 6 6 6
Total Sell Transactions 6 6 7 8
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 360
  Page 10 of 15  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-10-24 4 AS $127.74 $13,735,116 D/D (107,524) 20,661     -
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-10-24 4 OE $13.71 $1,330,389 D/D 89,400 128,185     -
   Ingram Douglas S President & CEO   •       •      –    2018-08-15 4 B $125.26 $2,004,211 D/D 16,000 399,250 2.81     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-08-08 4 D $121.02 $726,120 D/D (6,000) 22,766     -
   Howton David T SVP, General Counsel   •       –      –    2018-08-08 4 D $121.02 $822,936 D/D (6,800) 28,071     -
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-08-08 4 D $121.02 $1,028,791 D/D (8,501) 38,785     -
   Howton David T SVP, General Counsel   •       –      –    2018-07-16 4 AS $136.46 $6,823,000 D/D (50,000) 34,871     -
   Howton David T SVP, General Counsel   •       –      –    2018-07-16 4 OE $13.71 $692,691 D/D 50,000 72,719     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-07-09 4 AS $137.32 $4,638,944 D/D (33,782) 28,766     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-07-09 4 OE $13.71 $465,415 D/D 33,782 40,680     -
   Barry Richard Director   –       •      –    2018-06-27 4 AS $130.34 $9,775,500 D/D (75,000) 3,170,432     -
   Ingram Douglas S President & CEO   •       •      –    2018-06-26 4 D $135.53 $5,007,291 D/D (36,946) 383,250     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-05-22 4 D $89.22 $128,031 D/D (1,435) 28,766     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-05-22 4 OE $0.00 $0 D/D 4,876 30,201     -
   Howton David T SVP, General Counsel   •       –      –    2018-05-22 4 D $89.22 $139,719 D/D (1,566) 34,871     -
   Howton David T SVP, General Counsel   •       –      –    2018-05-22 4 OE $0.00 $0 D/D 5,319 36,437     -
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-05-22 4 D $89.22 $180,581 D/D (2,024) 47,286     -
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-05-22 4 OE $0.00 $0 D/D 6,649 49,310     -
   Ruff Shamim SVP, Chief Regulatory Affairs   •       –      –    2018-05-22 4 D $89.22 $116,432 D/D (1,305) 31,936     -
   Ruff Shamim SVP, Chief Regulatory Affairs   •       –      –    2018-05-22 4 OE $0.00 $0 D/D 4,432 33,241     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-03-15 4 D $81.22 $51,412 D/D (633) 25,325     -
   Cumbo Alexander SVP, Chief Commercial Officer   •       –      –    2018-03-15 4 OE $13.71 $51,600 D/D 2,500 25,767     -
   Howton David T SVP, General Counsel   •       –      –    2018-03-15 4 D $81.22 $55,230 D/D (680) 31,118     -
   Howton David T SVP, General Counsel   •       –      –    2018-03-15 4 OE $13.71 $55,382 D/D 2,500 31,727     -
   Mahatme Sandesh EVP, CFO & CBO   •       –      –    2018-03-15 4 D $81.22 $59,615 D/D (734) 42,661     -
  360 Records found
  Previous  10  11  12  13  14  15   
  Page 10 of 15
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us